CN1130531A - Medicine for preventing and curing altitude disease - Google Patents
Medicine for preventing and curing altitude disease Download PDFInfo
- Publication number
- CN1130531A CN1130531A CN 95119857 CN95119857A CN1130531A CN 1130531 A CN1130531 A CN 1130531A CN 95119857 CN95119857 CN 95119857 CN 95119857 A CN95119857 A CN 95119857A CN 1130531 A CN1130531 A CN 1130531A
- Authority
- CN
- China
- Prior art keywords
- medicine
- preventing
- curing
- altitude
- effect
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
A medicine for preventing and curing altitude disease with cure rate up to over 90% and no toxic by-effect is prepared from rhodiola rosea (2-99 wt.%), seabuckthorn (0-90) and wolfberry fruit (0-90). It can regulate unbalanced oxygen free radical metabolism, reduce the pressure-volume of haematochrome and erythrocyte greatly and improve the filter index of erythrocyte distinctly.
Description
The invention belongs to a kind of Chinese herbal medicine, relate in particular to a kind of medicine of preventing and treating altitude sickness.
Studies show that plateau climate has certain influence to health, live in the easy aging of the geographic resident of high altitude anoxia for a long time and may suffer from high altitude erythrocytosis (high red disease), the not congruent disease of high altitude heart disease and altitude acclimatization.In recent years research discloses, and high altitude anoxia has caused the interior radical metabolism disorder of resident's body, mainly shows as superoxide dismutase (SOD) reduction that malonaldehyde (MDA) raises and the oxygen-derived free radicals ability is removed in reflection of oxygen-derived free radicals content in the antimer.This radical metabolism disorder is to cause one of major reason of high protoplast " senilism ", " senilism " and the generation of some high altitude diseases, development.At present relevant people from Plain enters the unbalance control of the interior radical metabolism of body behind the plateau and prevents and treats altitude sickness and yet there are no report by improving radical metabolism, to high altitude erythrocytosis, still there is not sophisticated therapeutic scheme, the serious patient takes therapy of blood-letting that certain curative effect is arranged, but has been the respite effect.Also the someone adopts Integrative Chinese-Western, and as diethylstilbestrol+Decoction of Gentiana for Purging the Liver-fire, clinical more rate is 51.7%, but the diethylstilbestrol side effect is big, unsuitable prolonged application.Some other medicine also can try out as low molecule dextrose liver, aminophylline etc., but curative effect is limited.
The purpose of this invention is to provide a kind of medicine of preventing and treating high protoplast's senilism and all kinds altitude sickness, it has for the intravital radical metabolism disorder of high aborigines regulates and the improvement effect, and high altitude erythrocytosis is had better therapeutic effect.The curative effect height, nontoxic, side effect.
The present invention is achieved in that with Radix Rhodiolae, Fructus Hippophae, Fructus Lycii be raw material, and its percentage by weight is: Radix Rhodiolae 2-99%, Fructus Hippophae 0-90%, Fructus Lycii 0-90%.Wherein optimum formula is a Radix Rhodiolae 30-70%, and Fructus Hippophae 15-55% is respected Qi 15-55%.
Medicine provided by the invention can make the malonaldehyde (MDA) of body reflection oxygen-derived free radicals content obviously reduce, the ability that please remove oxygen-derived free radicals strengthens, be that superoxide dismutase (SOD) raises, show that this medicine has adjusting and improvement effect to radical metabolism disorder in the human body, help adapting to hypoxic plateau environment better after people from Plain enters the plateau, the prevention altitude sickness is had positive role.This medicine obviously improves Radical Metabolism disorder in the human body, and high red disease patient's hematochrome and red blood cell hematocrit are significantly descended, and the erythrocyte FI is clearly better, and clinical cure rate reaches more than 90%, nontoxic, side effect.
Manufacturing process of the present invention is conventional technology, can make oral liquid, capsule, tablet, various dosage forms such as powder.
Further specify the present invention below in conjunction with embodiment.
Embodiment 1, and its prescription (percentage by weight) is: Radix Rhodiolae 80%, and Fructus Hippophae 18%, Fructus Lycii 2% is made oral liquid.The main cause that environment of low oxygen plateau has a negative impact to human body is that aerial oxygen dividing potential drop and blood oxygen pressure reduce, this medicine has in the rising, the effect of the interior blood oxygen pressure of old human body, the anoxic conditions of high aborigines' in-vivo tissue has obtained to a certain degree improving after the medication, make it to adapt to better environment of low oxygen plateau, positive effect is arranged for premature senescence resistance.
Embodiment 2, and its prescription (percentage by weight) is: Radix Rhodiolae 8%, and Fructus Hippophae 80%, Fructus Lycii 12% is made tablet, and people from Plain entered behind the plateau the unbalance and altitude sickness of free radical metabolism obvious preventive and therapeutic effect.
Embodiment 3, and its prescription (percentage by weight) is: Radix Rhodiolae 50%, and Fructus Hippophae 25%, Fructus Lycii 25% is made capsule, and the malonaldehyde of reflection oxygen-derived free radicals content in the high red disease patient body is reduced, and the ability of removing oxygen-derived free radicals strengthens.Hematochrome and red blood cell hematocrit significantly descend, and the erythrocyte FI is clearly better, and clinical cure rate can reach more than 90%.
As if after adding an amount of Radix Ginseng and vitamin medicaments, various types of altitude sickness also there are certain prevention and therapeutical effect in this medicine composition.
Claims (2)
1, a kind of medicine of preventing and treating altitude sickness, it is characterized in that its pharmaceutical formulation (percentage by weight) is: Radix Rhodiolae 2-99%, Fructus Hippophae 0-90%, Fructus Lycii 0-90%.
2, medicine according to claim 1 is characterized in that its optimum formula (percentage by weight) is: Radix Rhodiolae 30-70%, Fructus Hippophae 15-55%, Fructus Lycii 15-55%.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 95119857 CN1130531A (en) | 1995-12-07 | 1995-12-07 | Medicine for preventing and curing altitude disease |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 95119857 CN1130531A (en) | 1995-12-07 | 1995-12-07 | Medicine for preventing and curing altitude disease |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN1130531A true CN1130531A (en) | 1996-09-11 |
Family
ID=5082195
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 95119857 Pending CN1130531A (en) | 1995-12-07 | 1995-12-07 | Medicine for preventing and curing altitude disease |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1130531A (en) |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1090916C (en) * | 1999-12-24 | 2002-09-18 | 中国人民解放军军事医学科学院卫生学环境医学研究所 | Oral liquid for preventing altitude disease and its preparing process |
| CN101190249B (en) * | 2006-11-30 | 2011-05-18 | 四川宇妥藏药药业有限责任公司 | Composition for preventing and controlling high-altitude disease and preparation method thereof |
| CN101190250B (en) * | 2006-11-30 | 2011-11-02 | 四川宇妥藏药药业有限责任公司 | Chewable tablets for preventing and controlling high-altitude disease and preparation method thereof |
| CN110538242A (en) * | 2019-09-26 | 2019-12-06 | 西藏中孚医药科技有限公司 | Preparation process of compound rhodiola rosea and salvia miltiorrhiza buccal tablets |
-
1995
- 1995-12-07 CN CN 95119857 patent/CN1130531A/en active Pending
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1090916C (en) * | 1999-12-24 | 2002-09-18 | 中国人民解放军军事医学科学院卫生学环境医学研究所 | Oral liquid for preventing altitude disease and its preparing process |
| CN101190249B (en) * | 2006-11-30 | 2011-05-18 | 四川宇妥藏药药业有限责任公司 | Composition for preventing and controlling high-altitude disease and preparation method thereof |
| CN101190250B (en) * | 2006-11-30 | 2011-11-02 | 四川宇妥藏药药业有限责任公司 | Chewable tablets for preventing and controlling high-altitude disease and preparation method thereof |
| CN110538242A (en) * | 2019-09-26 | 2019-12-06 | 西藏中孚医药科技有限公司 | Preparation process of compound rhodiola rosea and salvia miltiorrhiza buccal tablets |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR20010015618A (en) | A medicament for treating recurrent ulcer of mouth and Behcet's syndrome | |
| CN101028446A (en) | Medicine for symptomatic dry eye | |
| CN1130531A (en) | Medicine for preventing and curing altitude disease | |
| CN101933963B (en) | Nasal in-situ gel for treating headache | |
| CN101926890B (en) | Medicament for treating xerophthalmia | |
| CN1336169A (en) | Medicated toothpaste | |
| CN112353729A (en) | Toothpaste for relieving oral ulcer and relieving swelling and pain and preparation method thereof | |
| CN101961411B (en) | Medicament for treating aphthosis and preparation method thereof | |
| CN111658690A (en) | Nasal mask capable of releasing drug and relieving rhinitis, solid drug release agent and preparation method | |
| CN1242790C (en) | Composition for improving life quality of cancer patients | |
| CN101129684A (en) | Medicament for treating children's hernia | |
| CN111358927B (en) | Pujiang medicinal composition and application thereof | |
| CN112933122B (en) | Traditional Chinese medicine external medicine for treating recurrent oral ulcer | |
| CN1076203C (en) | Medicine for curing lithangiuria | |
| CN102949567A (en) | Medicinal capsule for removing chloasma and preparation method thereof | |
| CN116688012B (en) | Buccal tablet for preventing influenza | |
| KR20110056459A (en) | Composition for prevention and improvement of periodontal disease | |
| CN1106282A (en) | Medicament for treatment of cancer | |
| CN107149665B (en) | Traditional Chinese medicine for treating interstitial lung disease and preparation method thereof | |
| CN105902722B (en) | Traditional Chinese medicine composition for treating leucoderma as well as preparation method and application thereof | |
| CN1057926C (en) | Medicinal composition for curing gastrointestinal disease | |
| CN1092522C (en) | Traditional Chinese medicinal capsule for treating cough with dyspnea | |
| CN104799391A (en) | Oolong tea polysaccharide compound type weight-losing solid beverage and application | |
| CN117482201A (en) | Traditional Chinese medicine composition for preventing and treating rhinitis as well as preparation method and application thereof | |
| CN117257870A (en) | Composition for preventing and relieving sub-health of joints and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C06 | Publication | ||
| PB01 | Publication | ||
| C01 | Deemed withdrawal of patent application (patent law 1993) | ||
| WD01 | Invention patent application deemed withdrawn after publication |